Contrasting effects of citalopram and reboxetine on waking salivary cortisol

Psychopharmacology

Volumn 167, Issue 1, 2003, Pages 112-114

  Harmer, C J ^a   Bhagwagar, Z ^a   Shelley, N ^a   Cowen, P J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Citalopram; HPA axis; Reboxetine; Salivary cortisol

Indexed keywords

CITALOPRAM; PLACEBO; REBOXETINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SALIVA LEVEL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROENDOCRINOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; WAKEFULNESS;

EID: 0038746882     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1417-y     Document Type: Article

References (20)

1. Anderson IM, Deakin JFW, Miller HEJ (1996) The effects of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology 128:74-82
2. Bhagwagar Z, Hafizi S, Cowen PJ (2002) Acute citalopram administration produces correlated increases in plasma and salivary cortisol. Psychopharmacology 163:118-120
3. Hennig J, Lange N, Haag A, Rohrmann S, Netter P (2000) Reboxetine in a neuroendocrine challenge paradigm: evidence for high cortisol responses in healthy volunteers scoring high on subclinical depression. Int J Neuropsychopharmacol 3:193-201
4. Hill SA, Taylor MJ, Harmer CJ, Cowen PJ (2003) Acute reboxetine administration increases plasma and salivary cortisol. J Psychopharmacol (in press)
5. Inder WJ, Prickett TC, Mulder RT, Donald RA, Joyce PR (2001) Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology 156:73-78
6. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH (1999) Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 61:154-162
7. Knutson B, Wolkowitz OM, Cole SW, Moore EA, Johnson RC, Terpstra J, Turner RA, Reus VI (1998) Selective alteration of personality and social behaviour by serotonergic intervention. Am J Psychiatry 155:373-379
8. Laakmann G, Hinz A, Voderholzer U, Daffner C, Muller OA, Neuhauser H, Neulinger E, Wittmann M (1990) The influence of psychotropic drugs and releasing hormones on anterior pituitary hormone secretion in healthy subjects and depressed patients. Pharmacopsychiatry 23:18-26
9. 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43:547-573
10. O'Keane V, McLoughlin D, Dinan TG (1992) D-Fenfluramine-induced prolactin and cortisol release in major depression: response to treatment. J Affect Disord 26:143-150
11. Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391-404
12. Pruessner JC, Wolf OT, Hellhammer DH, Buske-Kirschbaum AB, Von Auer K, Jobst S, Kaspers F, Kirschbaum C (1997) Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 61:2539-2549
13. Ribeiro SCM, Tandon R, Grunhaus L, Greden JF (1993) The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150:1618-1629
14. Sagud M, Pivac N, Muck-Seler D, Jakovljevic M, Mihaljevic-Peles A, Korsic M (2002) Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients. Neuropsychobiology 45:139-143
15. 1A receptor sensitivity. Psychopharmacology 132:296-302
16. Schmidt-Reinwald A, Pruessner JC, Hellhammer DH, Federenko I, Rohleder N, Schurmeyer TH, Kirschbaum C (1999) The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci 64:1653-1660
17. Späth-Schwalbe E, Scholler T, Kern W, Fehm HL, Born J (1992) Nocturnal adrenocorticotropin and cortisol secretion depends on sleep duration and decreases in association with spontaneous awakening in the morning. J Clin Endocrinol Metab 75:1431-1435
18. Stahl SM, Nierenberg AA, Gorman JM (2001) Evidence of early onset of antidepressant effect in randomised controlled trials. J Clin Psychiatry 62:17-23
19. Versiani M, Amin M, Chouinard G (2000) Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depression. J Clin Psychopharmacol 20:28-34
20. Wüst S, Federenko I, Hellhammer DH, Kirschbaum C (2000) Genetic factors, perceived chronic stress, and the free cortisol response to wakening. Psychoneuroendocrinology 25:707-720